About Simpex Pharma Private Limited
Data last updated:
Simpex Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33112DL1997PTC085657. Its GSTIN is 07AABCS7865B1ZC (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Naresh Santhanam and Ajay Kumar Mishra.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 302 3rd Floor, Ansal Tower 38, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.72 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹5.18 Cr (net margin 7.3%) and EBITDA of ₹10.37 Cr (EBITDA margin 14.7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 27% over five years.
The company has about 157 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Simpex Pharma. As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹35.37 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 2 cases are pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹14.99 Cr; the latest was in October 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Nucrest Pharma Private Limited with revenue of ₹71.97 Cr. The company has 7 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 34 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website simpexpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFlat No – 302 3rd Floor, Ansal Tower 38, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Simpex Pharma Private Limited
The main business activity of Simpex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Simpex Pharma Private Limited FY 2025 filings available
Simpex Pharma Private Limited reported revenue of ₹70.72 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Simpex Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 24% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Simpex Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.37 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.18 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Simpex Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Simpex Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Simpex Pharma Private Limited
Simpex Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nucrest Pharma Private Limited | ₹71.97 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Momentum Biotech Private Limited | ₹71.34 Cr (FY 2025) | •••• | •••• | 147.0% | •••• | Jaipur, Rajasthan, India |
| Synnat Pharma Private Limited | ₹71.34 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Sanjivani Paranteral Limited Listed | ₹71.31 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Mumbai, Maharashtra, India |
| Geeta Laboratories Private Limited | ₹71.23 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Simpex Pharma Private Limited this company | ₹70.72 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Global Pharma Healthcare Private Limited | ₹70.65 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
| Jaahnavee Lifesciences Private Limited | ₹70.16 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| World Chem Industries Private Limited | ₹70.13 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Panoli, Gujarat, India |
| Aneta Pharmaceuticals Private Limited | ₹70.12 Cr (FY 2025) | •••• | •••• | 671.0% | •••• | Ahmedabad, Gujarat, India |
| Gluconate Health Ltd | ₹70.08 Cr (FY 2020) | •••• | •••• | 7.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Simpex Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Simpex Pharma Private Limited
Simpex Pharma Private Limited is audited by Kashyap Sikdar & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Kashyap Sikdar & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Simpex Pharma Private Limited
Simpex Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Santhanam | Director | 15 Feb 2010 | 16 Years 8 Months | Current |
| Ajay Kumar Mishra | Director | 06 Apr 2010 | 16 Years 6 Months | Current |
| Piyush Kumar Singh | Director | 02 Jan 2020 | 6 Years 9 Months | Current |
Ownership and Shareholding of Simpex Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Simpex Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2025 | Others | ₹12 Cr | Open |
| 10 Jan 2022 | Others | ₹9.95 Cr | Satisfied |
| 14 Apr 2011 | Corporation Bank | ₹5.42 Cr | Satisfied |
| 21 Oct 2009 | Corporation Bank | ₹10 Cr | Satisfied |
| 01 Sep 2009 | Corporation Bank | ₹10 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of Simpex Pharma Private Limited
Simpex Pharma Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹14.99 Cr; the latest was in October 2018.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2008 | Funding round | ₹10 Cr | Investors: Baylake Finance S.A, an individual |
| Mar 2008 | Funding round | ₹4 Cr | Investors: 4 individuals |
| Mar 2007 | Funding round | ₹98.8 Lakh | Investors: 4 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Simpex Pharma Private Limited
Simpex Pharma Private Limited has 5 court cases on record: 2 filed by Simpex Pharma, 3 filed against it. 2 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 2 | 2 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed by the company against Molekule (India) Private Limited | Disposed |
| High Court of Uttarakhand | Court case (CLR) | Filed against the company by an individual | Pending |
| High Court of Uttarakhand | Court case (CLR) | Filed by the company against an individual | Pending |
| District court, Pauri Garhwal, Uttarakhand | Court case (Small Cause Court suits) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CRL.M.C.) | Filed against the company by an individual | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Simpex Pharma Private Limited
Simpex Pharma Private Limited has 7 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Kalapi Print Pack LLP | •••• | •••• | •••• |
| Ideal Cures Private Limited | •••• | •••• | •••• |
| Spincotech Systems LLP | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Omega Printopack Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 7 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Simpex Pharma Private Limited
Simpex Pharma operates one associated brand: Simpex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medicines in India. | simpexpharma.com |
Employees and EPFO Compliance at Simpex Pharma Private Limited
Simpex Pharma Private Limited has a workforce of 157 employees as of Sep 23, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Simpex Pharma Private Limited
Simpex Pharma Private Limited has 13 board changes on record since 2010: 3 appointments and 10 cessations. The latest: Piyush Kumar Singh ceased to be Additional Director on 31 Dec 2020.
16 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Simpex Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Simpex Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Simpex Pharma Private Limited
Simpex Pharma has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCS7865B1ZC | Delhi | Active | 01 Jul 2017 |
| 05AABCS7865B1ZG | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Simpex Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simpex Pharma Private Limited
Simpex Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 1997 (29+ years old) and is registered under CIN U33112DL1997PTC085657.
Simpex Pharma reported revenue of ₹70.72 Cr for FY 2025 (up 24% YoY).
Simpex Pharma has 3 current directors:
- Naresh Santhanam - Director
- Ajay Kumar Mishra - Director
- Piyush Kumar Singh - Director
Simpex Pharma reported a net profit of ₹5.18 Cr (net margin 7.3%) and EBITDA of ₹10.37 Cr (EBITDA margin 14.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Simpex Pharma is 35% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Simpex Pharma is 07AABCS7865B1ZC, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 05AABCS7865B1ZG (Uttarakhand).
The CIN (Corporate Identification Number) of Simpex Pharma is U33112DL1997PTC085657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Simpex Pharma has 5 court cases on record: 2 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Simpex Pharma was incorporated on 07 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Simpex Pharma has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹14.99 Cr; the latest was in October 2018.
The peers of Simpex Pharma by revenue are Nucrest Pharma Private Limited, Momentum Biotech Private Limited, Synnat Pharma Private Limited, Sanjivani Paranteral Limited, Geeta Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Piyush Kumar Singh ceased to be Additional Director on 31 Dec 2020. Piyush Kumar Singh was appointed as Director on 02 Jan 2020. Sheetal Prasad Singh ceased to be Director on 02 Jan 2020. Simpex Pharma has 13 board changes on record in total.